Second Nasdaq Delisting Notice Hits Arcadia Biosciences Over Equity Shortfall
RKDA sits 24% above its 52-week low of $0.38.
Summary
Arcadia Biosciences received a second Nasdaq delisting notice for failing the $2.5 million minimum stockholders' equity requirement, reporting equity of only $633,000. The company has until October 15, 2026 to submit a compliance plan.
Key Events · Legal and Risk Events · RKDA
-
Second Nasdaq Delisting Notice
Nasdaq notified Arcadia on August 31, 2026 that its stockholders' equity of $633,000 as of June 30, 2026 falls below the $2.5 million minimum required under Listing Rule 5550(b)(1).
-
No Alternative Listing Standards Met
The company does not meet the alternative market value of listed securities or net income from continuing operations standards, leaving no immediate path to compliance.
-
Compliance Plan Deadline
Arcadia has 45 calendar days, until October 15, 2026, to submit a plan to Nasdaq. If accepted, Nasdaq may grant up to 180 days to evidence compliance.
-
Compounding Prior Bid-Price Deficiency
This equity-requirement notice follows a separate bid-price delisting notice received August 4, 2026, disclosed in an 8-K on August 7, 2026.
Analysis · RKDA · Energy & Transportation
A second Nasdaq delisting notice landed on August 31, 2026, this time for failing the minimum stockholders' equity requirement of $2.5 million. Arcadia Biosciences reported equity of just $633,000 as of June 30, 2026, and does not meet the alternative market value or net income standards. This compounds the bid-price deficiency disclosed on August 7, 2026, and the company now faces an October 15, 2026 deadline to submit a compliance plan. With a market cap near $1.1 million and a going-concern warning already on file, the path to regaining compliance is narrow and likely requires a reverse split or significant capital raise.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.8% of the 571 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RKDA was trading at $0.47 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $0.38 to $6.71. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.